TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Consun Pharmaceutical Group Ltd. ( (HK:1681) ).
Consun Pharmaceutical Group Ltd. has announced the establishment of a Nomination Committee within its Board of Directors, effective from June 2025. This committee, primarily composed of independent non-executive directors, will oversee the nomination process for board members, ensuring diversity and independence in its composition. The move is aimed at enhancing corporate governance and ensuring a robust selection process for board appointments.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Average Trading Volume: 2,346,318
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.36B
For a thorough assessment of 1681 stock, go to TipRanks’ Stock Analysis page.